European Archives - Page 822 of 1110 - European Medical Journal

Potential Methods for Treating Hepatitis Developed by Researchers

Two new methods of potentially treating hepatitis have been discovered by researchers from Maastricht University, Maastricht, Netherlands. It is hoped…

Presenting EMJ 3.1

Say hello to the first of four editions of the European Medical Journal for 2018. To welcome the start of spring, EMJ 3.1 provides a breath of fresh air, blossoming with interdisciplinary insights for everyone to enjoy over the coming months.

European League Against Rheumatism Recommendations for Early Arthritis: What Has Changed?

Rheumatoid arthritis (RA) is a chronic, disabling, inflammatory, autoimmune disease that affects approximatively 0.4–1.0% of the population. Immune…

European Medical Journal 3.1 2018

The European Medical Journal leaps into March with the year’s first edition of our flagship publication, EMJ 3.1. This edition is packed with an…

Current Approach to the Treatment of Coronary Chronic Total Occlusions

Coronary chronic total occlusions (CTO), in spite of excellent progress in the field of medicine, remain a great challenge for interventional cardiologists.

Interleukin-23 in Psoriasis: Integrating New Therapies in the Current Treatment Landscape

Prof Reich welcomed delegates to the satellite symposium and explained that the aims of the meeting were to introduce the clinical role of targeted…

From Registry Data to Real-Life Experiences: A Holistic Perspective of Psoriasis Treatment

Registries provide very high-quality data on the persistence of different therapies in the real world and can be used to compare and guide therapeutic…

Interleukin-23 Inhibition as a Strategy to Treat Immune-Mediated Inflammatory Diseases

The satellite symposium comprised two short presentations aimed at providing an overview of the rationale for the use of interleukin (IL)-23 inhibition…

Mission: Rapid Action and Lasting Remission: A Focus on Disease Progression in Ulcerative Colitis

Do flares of ulcerative colitis (UC) cause long-term bowel damage? Dr Sandborn opened the symposium by challenging the audience to think about their…

Targeting Mucosal Healing: Optimising Results with Early Appropriate Therapy in Crohn’s Disease

Given the progressive nature of Crohn’s disease (CD), Prof Panés made a case for timely intervention in at-risk patients to achieve the ultimate goal of…